-
Mashup Score: 0Nonestrogen Treatments for Menopause - 7 day(s) ago
Panelists discuss alternative therapies for women who are not candidates for or choose not to use hormonal therapy, review nonhormonal treatment options recommended by the North American Menopause Society, and explore the growing importance of Level I evidence and consensus opinions in creating a more holistic view of available therapies, both hormonal and nonhormonal.
Source: www.patientcareonline.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0
Panelists discuss how early screening, timely intervention, and the use of teplizumab can improve outcomes for individuals with type 1 diabetes (T1D) by delaying disease progression and reducing complications like diabetic ketoacidosis.
Source: www.patientcareonline.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0
Javier Morales, MD, FACP, FACE; Shira Eytan, MD, FACE; Bethany Kinsey, NP; Quentin Van Meter, MD, and David Robertson, MD, discuss the progression and management of Type 1 diabetes, from early screening protocols through disease stages and intervention timing, emphasizing the critical importance of vigilant monitoring and prompt treatment to prevent severe complications.
Source: www.patientcareonline.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0
Panelists discuss how early screening, timely intervention with teplizumab, and a proactive, multidisciplinary approach can significantly delay the progression of type 1 diabetes (T1D) and improve patient outcomes.
Source: www.patientcareonline.comCategories: General Medicine News, General Journals & SocietTweet-
Don’t miss our Frontline Insights video series “Proactive Intervention: Strategies for Slowing Type 1 Diabetes Progression!” With each episode, you’ll learn insights on T1D, strategies for delaying progression, and more! 💉💊 #type1diabetes #diabetescare https://t.co/mvg502BRWp https://t.co/b4yT6NCs9Q
-
-
Mashup Score: 0
Javier Morales, MD, FACP, FACE; Shira Eytan, MD, FACE; Bethany Kinsey, NP; Quentin Van Meter, MD, and David Robertson, MD, discuss the progression and management of Type 1 diabetes, from early screening protocols through disease stages and intervention timing, emphasizing the critical importance of vigilant monitoring and prompt treatment to prevent severe complications.
Source: www.patientcareonline.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0Ahead of the Curve: Early Interventions for Delaying Type 1 Diabetes - 1 month(s) ago
Javier Morales, MD, FACP, FACE; David Robertson, MD; Andrea Stallings, PA, and Shira Eytan, MD, FACE, examine the comprehensive burden of Type 1 diabetes, from screening guidelines and disease staging to the critical importance of early intervention, emphasizing how delayed treatment in Stage 2 can lead to severe complications and diminished therapeutic opportunities.
Source: www.patientcareonline.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 7Pain Expert Edward Mariano, MD, MAS, Highlights Journavx and the Newly-Approved Nonopioid's Mechanism of Action - 1 month(s) ago
Mariano, a well-known researcher in regional anesthesiology and acute pain medicine, talks about the Journavx difference, including the drug’s safety profile.
Source: www.patientcareonline.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Aneesa Das, MD, and Jeanne Caligiuri, MD, examine the comprehensive landscape of obstructive sleep apnea, from its fundamental pathophysiology and health impacts to diagnostic approaches and systemic barriers that challenge effective identification and treatment of this prevalent sleep disorder.
Source: www.patientcareonline.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 1Ahead of the Curve: Early Interventions for Delaying Type 1 Diabetes - 2 month(s) ago
Javier Morales, MD, FACP, FACE; David Robertson, MD; Andrea Stallings, PA, and Shira Eytan, MD, FACE, examine the comprehensive burden of Type 1 diabetes, from screening guidelines and disease staging to the critical importance of early intervention, emphasizing how delayed treatment in Stage 2 can lead to severe complications and diminished therapeutic opportunities.
Source: www.patientcareonline.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0
Panelists discuss how early screening, timely intervention, and the use of teplizumab can improve outcomes for individuals with type 1 diabetes (T1D) by delaying disease progression and reducing complications like diabetic ketoacidosis.
Source: www.patientcareonline.comCategories: General Medicine News, General Journals & SocietTweet-
In our latest Frontline Insights video series “Taking Charge Early: Navigating Treatment Options to Delay T1D Progression,” our panelists share their expertise on type 1 diabetes screening, care, and more. Don’t miss it! 💉💊 #type1diabetes #diabetescare https://t.co/PHCOSWrxbE https://t.co/5108z2Tg8v
-
Non-hormonal options for menopause: Explore evidence-based insights in Episode 8 of VMS and Menopause: https://t.co/5rGbYYdJ8a #MenopauseCare #ClinicalPractice https://t.co/Pen969SSoi